ARCHIVES

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

This article is from The Cancer Letter archive.

Vol. 01 No. 32 | August 8, 1975

Download PDF Visit The Full Archive

Related Articles

Vidaza For MDS Approved; sNDAs for Taxotere, Gemzar

May 28, 2004

FDA Approves Taxotere For Node+ Breast Cancer

August 27, 2004

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

NCI To Offer Planning Grants for New Centers

November 9, 1990

In Brief: Morton Leaves UCLA Surgical Oncology; Rall Resigns As NIH Deputy for Intramural Research

May 17, 1991